Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The PDUFA date of the Dopamine Agonist is fast approaching. Only a 12M market but every bit helps.
Expect that the dime resistance to be broken to the upside in the near future based on Mm activity. Keep an eye on the volume as new investors enter the arena. Stock is still very inexpensive.
Since Pyros has now listed its Vigabatrin product as commercialized, it is probable that Elite has started shipping for their inventory buildup. While Elite may not announce this commencement, NH should allude tothe manufacturing income at the November conference.
The 10 cent level remains an area of resistance but the next decent volume day should propel the price to the teens. Sitting here with Stuey enjoying the ride.
Maybe you should change your name to Weesell.
Expect some resistance at a dime as some long timers take some money off the table. Used cars have gone up in price.
Definition of a long term capital gain: A short term trade that didn't work out.
We are less than a month away from approval of the Dopamine agonist. Some posters here can use the pill to cure the dope of mine agonizing. Small market but every bit help as new sources of revenue get checked off on the list
Obviously Nasrat knows. Good question to pose at the November call but it may moot at that time if he does the right thing for himself and shareholders.
Currently Mikah shares 50% of the Adderall profits with Elite. Mikah should be paying 50 % of Kirkov's salary or sell the old Sungen share back to the company in the near future on terms that are fair.
Stock should be a teenager before the November call. Still a strong buy at these pre 10 cent level but not for long as new smart money takes out weak holders who are ready to move on.
Stock completes a head a shoulder pattern at around $4 a share. Needs news that the crash errors have been corrected with announcement of next launch. It's rocket science
Because a deal a deal unless you are a politician.
Nasrat stated that the BOD and Mikah agreed upon a price for the purchase of the Sungen share of Adderall profits but it was tabled due to the uncertainty of the company being able to self distribute lead by Kikov. Now that the company has shown good growth in the 1st fiscal year quarter ending June 30, with a good chance that it will continue when it reports in November, there is little reason not to complete the previously agreed to deal.
Unless you believe the expression, the King can do no wrong.
The pdufa date for the Oxycontin is 6/17/24 if my math is correct.
I also think that Elite will announce the purchase of the share of Adderall held by Mikah before the November earnings call.
Resistance at a dime then look for a breakout.
LOL. Do they still sell Edsels?
Save a mil here a mil there and you qualify as a penny pincher. Sometimes if you hit to pay the ask, the MM prints the buy for a few farthings less to make you feel good.
On a lighter note, the MMs set up a wall at 9 centavos on Friday. Once the stock is above 10 cents, expect a new breakout before next news release.
Ironically, there will be new investors, who didn't suffer the agony of holding a stock that was dead for 3 years, who will buy long timers shares for a dime and end up up with a 5-10 bagger, while the sellers drive used cars. Teslas are much cooler.
With Oxyconyin, Concerta, and Vyvanse ANDA filing in the near future, a bidder may appear sooner then expected.
As Elite becomes a competitive threat with yearly revenues climbing sharply, a market value of 750m or 75 cents is not unrealistic.
Would fit nicely with privately held Prasco who will be reliant on Elites production of Adderall xr starting in a few months Maybe a prelude to future manufacturing contracts.
Watching for continued uptick accumulation confirming the bright prospects.
Stock continues to be under accumulation with 1 million shares bought at 9 cents. Offers remain thin between 8-10 cents. Look for a breakout once 10 cent level is breached.
I wonder which box will be getting the next X.
Strong buy at these prices. Offers remain slim. One strong volume day will permit purchase of a new car for the kiddies
Hey King- When do you think items 2-12 will happen? I would like to front run some material news releases.
Looks like we will be in the 8-10 cent range for a while pending the next major event.
This stock is still undervalued. Those who sold at .03 can still buy at .08 and enjoy the ride up. I added at this level during the recent MMs stunt to depreciate the stock.
Nasrat has put together a good new team for extraordinary growth in sales, manufacture, and new high revenue ANDAs.
How much are you paid per post? Now I know why your posts are short. Hope you enjoyed your vacation.
Billy Rose was a world champion typist. Married Fanny Bryce and and did the Aquacade in Queens at the 1939 World's Fair. Famous for the line: a rise in Price per share does not need Nasdaq.
He posted 7 times in 52 seconds. Isn't AI great.
I actually had a nice bid at .076 which got hit just before the MM trade. You gotta be in it to win it.
Today was a good example of painting the tape.
It is illegal but rarely protected.
Likewise hitting the offer at the close is also not legal and also rarely achieves the goal of fooling the market.
My pie in the sky hope is that this stock will trade above a $1 for a few months to qualify for Nasdaq. Possible by next Summer once big new andas are approved and prasco manufacturing fees are substantial.
Todays stock price action is a good example why NWBO commenced a spoofing lawsuit against Citadel and some other nefarious MMs.
It looked like someone crossed 300k shares to have a good position before the next news event which can happen anytime within the next 30 days.
Tomorrows open will be very interesting. I would not be shocked if it gapped up.
As Groucho used to say: Last chance to beat the other couple. The secret word is BUY.
I expect that Elite will announce before the next Conference call that the BOD has concluded a deal with Mikah for the purchase of the 25% share of the profit from the Adderall profits that Nasrat purchased from Sungen.
Fun fact: The anadrome for Nasrat is Tarsan.
Per the 10 Q , page F-6, a large portion of the Manufacturing and Licensing fees now reported will be replaced with revenues from Direct Sales of pharma products to distributors for pharmacies and institutions.
The Direct Sales number will give shareholders a good indication as to Kirkov's success in selling directly.
The Manufacturing fees, with the subtraction of Lannett, should come down from the current $8M reported in the last quarter but should show a major increase in the 1st quarter in 2024 reflecting the manufacture of the Adderall XR for Prasco. Unfortunately shareholders will have to wait for the revenue report in April 2024 to see this result.
I expect to see 5 year stock price highs when revenue is reported on November 15.
Trading action, or lack thereof, on low volume appears to be MMs F'ing around. The first move up on decent volume was lead by a new MM ASCM who is now off the screen. This is often called the Move before the Move as people who know more than the average Joe take a position for a future event they know or expect to be announced.
Watch for volume increase as a harbinger of the next plateau which should put the stock in the 9-12 cent range.
Now that the CFO is back in place, I expect they will announce in the near future that earnings will be changed to a regular calendar year. They will have to restate the revenue so that they next announcement will be for the 3rd quarter ending on September 30.
Stock still undervalued so I don't mind manipulation on low volume. Only $50,000 in dollar volume. I'm still adding so I'd rather see and pay 8 cents than a dime or more.
As the Rolling Stones sing: Time time time is on our side. Yes it is!
Both King and IB last posted on this board on 9/8. I long believed that they were both the same person. Hopefully it is not a health issue.
It will be an easier pill to swallow.
Prasco total revenue in 2022 was 60 million. No breakdown of Adderall xr revenue.
Hey King. Are you ok? Can't remember a day that you failed to post.
Hope you didn't leave in protest for the rehire of the CFO.
My guesstimate is based upon Elite doing $50M in revenue this fiscal year up from $32M last year. Once the one or two "needle movers" are launched and the gross revenues are around $100m, I can see the $1 price you believe is possible. Chances are the company is sold before that. If not, we go on Nasdaq without the reverse.
As you know, NH indicated that he would reverse split the stock when the price was at a higher level in order to qualify for the listed price to qualify for Nasdaq.
At .30, a 1 for 10 reverse would move the price to $3. Shareholders holdings would be reduced to 10% of what you now own but the market value would remain the same.
I believe that is the plan unless someone buys the company for .50+ for a market cap of approximately $500M
Stock traded at .123 on 9/23/19 as an intra day high. When the next filing predicted by King is announced, we should trade above that price. Nice to see some nice steady accumulation, but volume is relatively tepid. I expect average daily volume to exceed 3 million plus shares a day as more eyes are on this very underappreciated corporation.
Thanks for info on Carter. If he didn't sell his 5 million shares, isn't he again considered an insider? I think then a form 4 would apply if he gets an option to purchase additional shares in the future. If so, the price should be at least 10 cents.
I'm interested in the Form 4 filing where we can see whether or not Carter Ward disposed of his previously held shares after he left. King do you have the info on his insider holding at the time he left the company?
RACKing your brain is a total waste of time. The ignore button is for removal of ignorance. Try it so you can have meaningful discussion on this board. We are entering an new and exciting era as multiple game changers are ripening to maturation.
Prasco obtained Teva/Shire Adderall xr on 2016 according to my search. Apparently Takeda has been manufacturing the product for them. Major pharmacies did not renew their purchases in 2021 with the exception of Walmark.
It appears that the manufacturing agreement with Takeda will expire at the end of this year and Elite will become its new manufacturer of the Authorized generic of Adderall XR starting on January 1.
It may be that Prasco opted to sign with Elite since they can make the drug cheaper than competitors. Perhaps a review of TAK financials will give a clue as to their manufacturing revenue from XR.
In any event, Elite will receive revenue for the manufacture of the XR commencing next Jan.1